BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37899088)

  • 1. Geospatial patterns of progress towards UNAIDS '95-95-95' targets and community vulnerability in Zambia: insights from population-based HIV impact assessments.
    Cuadros DF; Chowdhury T; Milali M; Citron DT; Nyimbili S; Vlahakis N; Savory T; Mulenga L; Sivile S; Zyambo KD; Bershteyn A
    BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37899088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geospatial Patterns of Progress towards UNAIDS "95-95-95" Targets and Community Vulnerability in Zambia.
    Cuadros DF; Chowdhury T; Milali M; Citron D; Nyimbili S; Vlahakis N; Savory T; Mulenga L; Sivile S; Zyambo K; Bershteyn A
    medRxiv; 2023 Apr; ():. PubMed ID: 37163012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress Towards UNAIDS's 95-95-95 Targets in Zimbabwe: Sociodemographic Constraints and Geospatial Heterogeneity.
    Chowdhury MT; Bershteyn A; Milali M; Citron D; Nyimbili S; Musuka G; Cuadros DF
    medRxiv; 2023 Jul; ():. PubMed ID: 37546877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping and characterising areas with high levels of HIV transmission in sub-Saharan Africa: A geospatial analysis of national survey data.
    Bulstra CA; Hontelez JAC; Giardina F; Steen R; Nagelkerke NJD; Bärnighausen T; de Vlas SJ
    PLoS Med; 2020 Mar; 17(3):e1003042. PubMed ID: 32142509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving beyond hotspots of HIV prevalence to geospatial hotspots of UNAIDS 95-95-95 targets in sub-Saharan Africa.
    Cuadros DF; Huang Q; Musuka G; Dzinamarira T; Moyo BK; Mpofu A; Makoni T; DeWolfe Miller F; Bershteyn A
    Lancet HIV; 2024 Jun; ():. PubMed ID: 38852597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
    PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
    Staveteig S; Croft TN; Kampa KT; Head SK
    PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Men missing from the HIV care continuum in sub-Saharan Africa: a meta-analysis and meta-synthesis.
    Nardell MF; Adeoti O; Peters C; Kakuhikire B; Govathson-Mandimika C; Long L; Pascoe S; Tsai AC; Katz IT
    J Int AIDS Soc; 2022 Mar; 25(3):e25889. PubMed ID: 35324089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
    Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
    J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV epidemic in Zambia: socio-demographic prevalence patterns and indications of trends among childbearing women.
    Fylkesnes K; Musonda RM; Kasumba K; Ndhlovu Z; Mluanda F; Kaetano L; Chipaila CC
    AIDS; 1997 Mar; 11(3):339-45. PubMed ID: 9147426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa.
    Sabapathy K; Balzer L; Larmarange J; Block L; Floyd S; Iwuji C; Wirth K; Ayles H; Fidler S; Kamya M; Petersen M; Havlir D; Dabis F; Moore J; Hayes R
    BMC Public Health; 2022 Dec; 22(1):2333. PubMed ID: 36514036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa.
    Seeley J; Bond V; Yang B; Floyd S; MacLeod D; Viljoen L; Phiri M; Simuyaba M; Hoddinott G; Shanaube K; Bwalya C; de Villiers L; Jennings K; Mwanza M; Schaap A; Dunbar R; Sabapathy K; Ayles H; Bock P; Hayes R; Fidler S;
    AIDS Behav; 2019 Apr; 23(4):929-946. PubMed ID: 30415432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographical Patterns of HIV Sero-Discordancy in High HIV Prevalence Countries in Sub-Saharan Africa.
    Cuadros DF; Abu-Raddad LJ
    Int J Environ Res Public Health; 2016 Aug; 13(9):. PubMed ID: 27589776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "The difference that makes a difference": highlighting the role of variable contexts within an HIV Prevention Community Randomised Trial (HPTN 071/PopART) in 21 study communities in Zambia and South Africa.
    Bond V; Chiti B; Hoddinott G; Reynolds L; Schaap A; Simuyaba M; Ndubani R; Viljoen L; Simwinga M; Fidler S; Hayes R; Ayles H; Seeley J;
    AIDS Care; 2016; 28 Suppl 3():99-107. PubMed ID: 27421057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported reasons for declining same-day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: results from a mixed-effects regression analysis.
    Pry J; Chipungu J; Smith HJ; Bolton Moore C; Mutale J; Duran-Frigola M; Savory T; Herce ME
    J Int AIDS Soc; 2020 Jul; 23(7):e25560. PubMed ID: 32618137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.
    Stelzle D; Godfrey-Faussett P; Jia C; Amiesimaka O; Mahy M; Castor D; Hodges-Mameletzis I; Chitembo L; Baggaley R; Dalal S
    PLoS Med; 2021 Jan; 18(1):e1003482. PubMed ID: 33428611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peer community health workers improve HIV testing and ART linkage among key populations in Zambia: retrospective observational results from the Z-CHECK project, 2019-2020.
    Lindsay BR; Mwango L; Toeque MG; Malupande SL; Nkhuwa E; Moonga CN; Chilambe A; Sakala H; Kafunda I; Olowski P; Olufunso A; Okuku J; Kancheya N; Mumba D; Hachaambwa L; Sheneberger R; Blanco N; Lavoie MC; Claassen CW
    J Int AIDS Soc; 2022 Nov; 25(11):e26030. PubMed ID: 36317821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.